Related Research Articles
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
In the United States, the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in 103,436,829 confirmed cases with 1,144,877 all-time deaths, the most of any country, and the 20th-highest per capita worldwide. The COVID-19 pandemic ranks first on the list of disasters in the United States by death toll; it was the third-leading cause of death in the U.S. in 2020, behind heart disease and cancer. From 2019 to 2020, U.S. life expectancy dropped by 3 years for Hispanic and Latino Americans, 2.9 years for African Americans, and 1.2 years for white Americans. These effects persisted as U.S. deaths due to COVID-19 in 2021 exceeded those in 2020, and life expectancy continued to fall from 2020 to 2021.
The COVID-19 pandemic was confirmed to have reached Oceania on 25 January 2020 with the first confirmed case reported in Melbourne, Australia. The virus has spread to all sovereign states and territories in the region. Australia and New Zealand were praised for their handling of the pandemic in comparison to other Western nations, with New Zealand and each state in Australia wiping out all community transmission of the virus several times even after re-introduction in the community.
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).
The COVID-19 pandemic in Cuba was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have spread to Cuba on 11 March 2020 when three Italian tourists tested positive for the virus.
The first confirmed case of the COVID-19 pandemic in the U.S. state of Connecticut was confirmed on March 8, although there had previously been multiple people suspected of having COVID-19, all of which eventually tested negative. As of January 19, 2022, there were 599,028 confirmed cases, 68,202 suspected cases, and 9,683 COVID-associated deaths in the state.
The COVID-19 pandemic in the U.S. state of Rhode Island is part of an ongoing worldwide viral pandemic of coronavirus disease 2019, a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2. As of August 18, 2022, there has been 414,931 confirmed cases of COVID-19 in Rhode Island, 89 of which are currently hospitalized, and 3,636 reported deaths. Rhode Island's COVID-19 case rate and death rate per capita are the highest and twentieth highest, respectively, of the fifty states since the start of the pandemic.
The COVID-19 pandemic in British Columbia forms part of an ongoing worldwide pandemic of coronavirus disease 2019 (COVID-19), a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On January 28, 2020, British Columbia became the second province to confirm a case of COVID-19 in Canada. The first case of infection involved a patient who had recently returned from Wuhan, Hubei, China. The first case of community transmission in Canada was confirmed in British Columbia on March 5, 2020.
The COVID-19 pandemic in the Isle of Man is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was confirmed to have reached the British crown dependency of the Isle of Man on 19 March 2020, when a man returning from Spain via Liverpool tested positive. Community transmission was first confirmed on 22 March on the island.
Operation Warp Speed (OWS) was a public–private partnership initiated by the United States government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation Warp Speed was on April 29, 2020, and the program was officially announced on May 15, 2020. It was headed by Moncef Slaoui from May 2020 to January 2021 and by David A. Kessler from January to February 2021. At the end of February 2021, Operation Warp Speed was transferred into the responsibilities of the White House COVID-19 Response Team.
Due to its severity, the COVID-19 pandemic has caused countries to send aid, as part of the international responses and management regarding the pandemic. Types of materials aided includes masks, medical supplies, personal protective equipment, money, and test kits. It started with aid to China as the virus spreads primarily there, and then internationally as it spreads globally. The destination of the aid ranges from hospitals, COVID-19 healthcare workers, research on the vaccine, to societies vulnerable. People donating includes the government of said country, notable people, organizations and institutions, charities, as well as regular people.
The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.
The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.
EpiVacCorona is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack of protective effectiveness of EpiVacCorona, which is still in use in Russia, has been reported in scientific literature and in the media. The vaccine consists of three chemically synthesized peptides that are conjugated to a large carrier protein. This protein is a fusion product of a viral nucleocapsid protein and a bacterial MBP protein. A phase III clinical trial to show whether or not the vaccine can protect people against COVID-19 was launched in November 2020 with more than three thousand participants. The conclusions and results of the trial have not been made public.
Claire Ann Deeks is a New Zealand anti-vaccine activist who has challenged the government's response to COVID-19. She was an unsuccessful candidate for the Advance NZ party in the 2020 general election, and set up the group Voices for Freedom (VFF), which distributed pamphlets that have been criticised by experts as containing COVID-19 misinformation about vaccines, lockdown and the wearing of masks. As a food blogger, Deeks promoted the paleo diet and "healthy" lunchboxes for children, and developed a petition to stop the rating system for foods used by the NZ and Australian governments. She is a former intellectual property lawyer.
The COVID-19 vaccination campaign in Germany began on 26 December 2020.
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy, effectiveness, and safety. As of November 2022, 40 vaccines are authorized by at least one national regulatory authority for public use:
References
- ↑ Graves, Helen (October 1, 2009). "Annie De Groot proves the power of one person". Boston Herald . Retrieved July 30, 2021.
- 1 2 "URI professor, vaccine pioneer honored by University of Chicago". URI News. University of Rhode Island. June 11, 2018. Retrieved July 30, 2021.
- ↑ MacMillan, John (June 15, 2020). "Dr. Annie De Groot '78: Designing a Vaccine". Grécourt Gate. Smith College . Retrieved July 30, 2021.
- ↑ Berkowitz, Bram (September 1, 2020). "Ocean State Update: The biggest Rhode Island tech and startup news From August". Rhode Island Innovation. Retrieved July 30, 2021.
- ↑ "7 Major Coronavirus Developments — RI's EpiVax to Raise $1.75M for Clinical Trial for Vaccine". GoLocalProv. April 8, 2020. Retrieved July 30, 2021.
- ↑ Tognini, Giacomo (April 1, 2020). "Coronavirus Business Tracker: How The Private Sector Is Fighting The Covid-19 Pandemic". Forbes . Retrieved July 30, 2021.